Fr. 239.00

Therapeutic Hypothermia

Englisch · Taschenbuch

Versand in der Regel in 6 bis 7 Wochen

Beschreibung

Mehr lesen

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Inhaltsverzeichnis

Global Brain Ischemia: Animal Studies.- Global Cerebral Ischemia: Clinical Studies.- Focal Cerebral Ischemia: Mechanisms.- Focal Cerebral Ischemia: Clinical Studies.- Traumatic Brain Injury: Laboratory Studies.- Traumatic Brain Injury: Clinical Studies.- Spinal Cord Ischemia and Trauma.- Asphyxia.- Neonatal Asphyxia.- Hemorrhagic Shock and Exsanguination Cardiac Arrest.- Adult Respiratory Distress Syndrome and Sepsis.- Liver Failure and Intracerebral Hypertension.- Myocardial Ischemia and Infarction.- Cooling Methods.- Detrimental Effects of Hypothermia.- Future Directions.

Zusammenfassung

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Produktdetails

Mitarbeit H Sterz (Herausgeber), H Sterz (Herausgeber), Fritz Sterz (Herausgeber), Fritz H. Sterz (Herausgeber), Samue Tisherman (Herausgeber), Samuel Tisherman (Herausgeber), Samuel A. Tisherman (Herausgeber)
Verlag Springer, Berlin
 
Sprache Englisch
Produktform Taschenbuch
Erschienen 21.10.2010
 
EAN 9781441937933
ISBN 978-1-4419-3793-3
Seiten 258
Abmessung 157 mm x 15 mm x 240 mm
Gewicht 416 g
Illustration XIV, 258 p.
Serien Molecular & Cellular Biology of Critical Care Medicine
Molecular & Cellular Biology of Critical Care Medicine
Themen Naturwissenschaften, Medizin, Informatik, Technik > Medizin > Klinische Fächer

C, Medicine, shock, critical care medicine, critical care, Intensive / Critical Care Medicine, Intensive Care Medicine, cerebral ischemia

Kundenrezensionen

Zu diesem Artikel wurden noch keine Rezensionen verfasst. Schreibe die erste Bewertung und sei anderen Benutzern bei der Kaufentscheidung behilflich.

Schreibe eine Rezension

Top oder Flop? Schreibe deine eigene Rezension.

Für Mitteilungen an CeDe.ch kannst du das Kontaktformular benutzen.

Die mit * markierten Eingabefelder müssen zwingend ausgefüllt werden.

Mit dem Absenden dieses Formulars erklärst du dich mit unseren Datenschutzbestimmungen einverstanden.